Paper Details

  1. Home
  2. Paper Details

The Predictive Value of Degree of Preference for Extended-Release Naltrexone for Treatment Adherence, Opioid Use, and Relapse.

Author: BrennaIda Halvorsen, FadnesLars Thore, GaulenZhanna, KunoeNikolaj, OpheimArild, SolliKristin K, TanumLars, Šaltytė BenthJūratė

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

Patient preference for extended-release naltrexone (XR-NTX) was associated with better long-term adherence to treatment and lower illicit opioid use. Patients who matched their preference for XR-NTX had lower illicit opioid use in the short term, while those who did not match their preference had higher long-term opioid use and relapse rates.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Extended-release naltrexone (XR-NTX) is effective for illicit opioid abstinence as an opioid maintenance treatment. To improve treatment outcomes, patient's preference for the modality of treatment is an important factor. OBJECTIVES: We aimed to test the relationship between baseline pr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1159/000518436

データ提供：米国国立医学図書館（NLM）

Understanding Patient Preference for Extended-Release Naltrexone

Extended-release naltrexone (XR-NTX) is a medication used to help people with [opioid use disorder] stay abstinent. But patients differ in their preferences for different treatment modalities. This study explores the relationship between patient preference for XR-NTX and their adherence to treatment, opioid use, and relapse risk.

Matching Treatment to Patient Preference

The study reveals that patient preference for XR-NTX, although not directly influencing short-term treatment outcomes, significantly impacts long-term adherence, opioid use, and relapse risk. This finding emphasizes the importance of matching patients to their preferred treatment modalities to optimize treatment success.

Optimizing Treatment Strategies for Opioid Use Disorder

The study highlights the need for individualized treatment approaches for opioid use disorder, taking into account patient preferences. This approach can contribute to improved treatment adherence, reduced opioid use, and a lower risk of relapse.

Dr.Camel's Conclusion

This study, like a careful navigator guiding a caravan through the desert, reveals the importance of matching patients to their preferred treatment modalities. It highlights the significance of individual preferences in achieving successful outcomes for individuals struggling with opioid use disorder.

Date :
  1. Date Completed 2022-01-10
  2. Date Revised 2022-01-10
Further Info :

Pubmed ID

34569487

DOI: Digital Object Identifier

10.1159/000518436

Related Literature

Article Analysis
・Effective treatment of opioid use
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.